The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Prevalence of the Metabolic Syndrome in Psoriasis: Results From the National Health and Nutrition Examination Survey, 2003-2006
Open accessAbstract
OBJECTIVES: To estimate the prevalence of the metabolic syndrome among individuals with psoriasis and to examine the association between these 2 conditions in the general US population. DESIGN: Cross-sectional health survey of a nationally representative random sample of the noninstitutionalized civilian US population. SETTING: The National Health and Nutrition Examination Survey, 2003-2006. PARTICIPANTS: The study included 6549 participants aged 20 to 59 years. MAIN OUTCOME MEASURES: Prevalence of the metabolic syndrome defined by the revised National Cholesterol Education Program Adult Treatment Panel III definition and odds ratios for associations after adjustment for age, sex, race/ethnicity, smoking status, and C-reactive protein levels. RESULTS: The prevalence of the metabolic syndrome was 40% among psoriasis cases and 23% among controls. According to 2008 US census data, the projected number of patients with psoriasis aged 20 to 59 years with the metabolic syndrome was 2.7 million. The univariate and multivariate odds ratios for patients with psoriasis and the metabolic syndrome were 2.16 (95% confidence interval, 1.16 to 4.03) and 1.96 (1.01 to 3.77), respectively. The most common feature of the metabolic syndrome among patients with psoriasis was abdominal obesity, followed by hypertriglyceridemia and low levels of high-density lipoprotein cholesterol. CONCLUSIONS: The prevalence of the metabolic syndrome is high among individuals with psoriasis. Given the serious complications associated with the metabolic syndrome, this frequent comorbidity should be recognized and taken into account in the long-term treatment of individuals with psoriasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
Grundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., Gordon, D. J., Krauss, R. M., Savage, P. J., Smith, S. C., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.169404 · Cited by 11,961
Ford, E. S., Giles, W. H., & Dietz, W. H. (2002) · JAMA · doi:10.1001/jama.287.3.356 · Cited by 6,698
Festa, A., D’Agostino, R., Howard, G., Mykkänen, L., Tracy, R. P., & Haffner, S. M. (2000) · Circulation · doi:10.1161/01.cir.102.1.42 · Cited by 2,358
Risk of myocardial infarction in patients with psoriasis
Gelfand, J. M., Neimann, A. L., Shin, D. B., Wang, X., Margolis, D. J., & Troxel, A. B. (2006) · JAMA · doi:10.1001/jama.296.14.1735 · Cited by 1,899 · cited 2×
“If present, the syndrome needs to be recognized as a potentially more lifethreatening factor than psoriasis given the serious associated complications.(31) The cornerstones of treatment of the syndrome are the management of weight and ensuring appropriate levels of physical activity as demonstrated by studies showing…”
BackgroundSelf-citationFord, E. S. (2005) · Diabetes Care · doi:10.2337/diacare.28.7.1769 · Cited by 1,710
Hu, G. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.10.1066 · Cited by 1,135
Prevalence of cardiovascular risk factors in patients with psoriasis
Neimann, A. L., Shin, D. B., Wang, X., Margolis, D. J., Troxel, A. B., & Gelfand, J. M. (2006) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.08.040 · Cited by 1,010
Self-citationStern, R. S., Nijsten, T., Feldman, S. R., Margolis, D. J., & Rolstad, T. (2004) · Journal of Investigative Dermatology Symposium Proceedings · doi:10.1046/j.1087-0024.2003.09102.x · Cited by 732
Mehta, N. N., Azfar, R. S., Shin, D. B., Neimann, A. L., Troxel, A. B., & Gelfand, J. M. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehp567 · Cited by 706
Self-citationPrevalence of metabolic syndrome in patients with psoriasis: a hospital-based case?control study
Gisondi, P., Tessari, G., Conti, A., Piaserico, S., Schianchi, S., Peserico, A., Giannetti, A., & Girolomoni, G. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.07986.x · Cited by 675
Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis
Sommer, D. M., Jenisch, S., Suchan, M., Christophers, E., & Weichenthal, M. (2006) · Archives of Dermatological Research · doi:10.1007/s00403-006-0703-z · Cited by 667
Prevalence and Treatment of Psoriasis in the United Kingdom: A Population-Based Study
Gelfand, J. M., Weinstein, R., Porter, S. B., Neimann, A. L., Berlin, J. A., & Margolis, D. J. (2005) · Archives of Dermatology · doi:10.1001/archderm.141.12.1537 · Cited by 600
Self-citationObesity as a cardiovascular risk factor
Sowers, J. R. (2003) · The American Journal of Medicine · doi:10.1016/j.amjmed.2003.08.012 · Cited by 584 · cited 1×
“These lifestyle interventions, particularly weight reduction, may even enhance the efficacy of psoriasis treatment, as demonstrated in a recent randomized trial(33) and by case reports of dramatic improvement of psoriasis after gastrectomy for obesity.(34) The close association with the metabolic syndrome and its comp…”
BackgroundInsulin resistance and cigarette smoking
Facchini, F. S., Hollenbeck, C. B., Jeppesen, J., Ida Chen, Y.-D., & Reaven, G. M. (1992) · The Lancet · doi:10.1016/0140-6736(92)90730-q · Cited by 545
The Risk of Mortality in Patients With Psoriasis: Results From a Population-Based Study
Gelfand, J. M., Troxel, A. B., Lewis, J. D., Kurd, S. K., Shin, D. B., Wang, X., Margolis, D. J., & Strom, B. L. (2007) · Archives of Dermatology · doi:10.1001/archderm.143.12.1493 · Cited by 533
Self-citationKurd, S. K., & Gelfand, J. M. (2009) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2008.09.022 · Cited by 519
Self-citationSetty, A. R. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.15.1670 · Cited by 485
Quality of life in patients with psoriasis
Bhosle, M. J., Kulkarni, A., Feldman, S. R., & Balkrishnan, R. (2006) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-4-35 · Cited by 377
Determinants of quality of life in patients with psoriasis: A study from the US population
Gelfand, J. M., Feldman, S. R., Stern, R. S., Thomas, J., Rolstad, T., & Margolis, D. J. (2004) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2004.04.014 · Cited by 367
Self-citationThe prevalence of psoriasis in African Americans: Results from a population-based study
Gelfand, J. M., Stern, R. S., Nijsten, T. E. C., Feldman, S. R., Thomas, J., Kist, J., Rolstad, T., & Margolis, D. J. (2004) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2004.07.045 · Cited by 310
Self-citationGisondi, P., Del Giglio, M., Di Francesco, V., Zamboni, M., & Girolomoni, G. (2008) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.26427 · Cited by 307
Psoriasis and metabolic disease: epidemiology and pathophysiology
Azfar, R. S., & Gelfand, J. M. (2008) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e3283031c99 · Cited by 297
Self-citationPsoriasis and the Risk of Diabetes and Hypertension: A Prospective Study of US Female Nurses
Qureshi, A. A., Choi, H. K., Setty, A. R., & Curhan, G. C. (2009) · Archives of Dermatology · doi:10.1001/archdermatol.2009.48 · Cited by 250
Self-citationManson, J. E., Ajani, U. A., Liu, S., Nathan, D. M., & Hennekens, C. H. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00568-4 · Cited by 245
Gisondi, P., Cotena, C., Tessari, G., & Girolomoni, G. (2008) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2007.02429.x · Cited by 171
Cardiovascular Disease and Risk Factors in Patients with Psoriasis and Psoriatic Arthritis
Tobin, A., Veale, D. J., FitzGerald, O., Rogers, S., Collins, P. M., O'Shea, D. B., & Kirby, B. (2010) · The Journal of Rheumatology · doi:10.3899/jrheum.090822 · Cited by 143
Prey, S., Paul, C. F., Bronsard, V., Puzenat, E., Gourraud, P., Aractingi, S., Aubin, F., Bagot, M., Cribier, B. J., Joly, P., et al. (2010) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2009.03564.x · Cited by 143
Effect of anti-tumor necrosis factor-α therapies on body mass index in patients with psoriasis
Saraceno, R., Schipani, C., Mazzotta, A., Esposito, M., Renzo, L. D., DELORENZO, A., & Chimenti, S. (2008) · Pharmacological Research · doi:10.1016/j.phrs.2008.02.006 · Cited by 133
The prevalence of psoriasis in Denmark
Brandrup, F., & Green, A. (1981) · Acta Dermato Venereologica · doi:10.2340/0001555561344346 · Cited by 127
Psoriasis and Dyslipidaemia: A Population-based Study
Dreiher, J., Weitzman, D., Davidovici, B. B., Shapiro, J. S., & Cohen, A. D. (2008) · Acta Dermato Venereologica · doi:10.2340/00015555-0510 · Cited by 104
Psoriasis Remission after Laparoscopic Roux-En-Y Gastric Bypass for Morbid Obesity
Higa, G., Szomstein, S., Soto, F. C., Brasecsco, O., Cohen, C., & Rosenthal, R. J. (2004) · Obesity Surgery · doi:10.1381/0960892041975569 · Cited by 102
Effect of Etanercept on Insulin Sensitivity in Nine Patients with Psoriasis
Marra, M., Campanati, A., Testa, R., Sirolla, C., Bonfigli, A. R., Franceschi, C., Marchegiani, F., & Offidani, A. (2007) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463200702000408 · Cited by 98
Martínez‐Abundis, E., Drateln, C. R.-V., Hernández-Salazar, E., & González-Ortíz, M. (2007) · Archives of Dermatological Research · doi:10.1007/s00403-007-0784-3 · Cited by 59
Chou, H., Hsu, L., Liu, C.-J., Teng, M., Wu, S., & Ko, Y. (2009) · Metabolism · doi:10.1016/j.metabol.2009.09.030 · Cited by 31
Alberti (1998) · doi:10.1002/(sici)1096-9136(199807)15:7<539::aid-dia668>3.0.co;2-s
Cited by
Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association
Benjamin, E. J., Blaha, M. J., Chiuve, S. E., Cushman, M., Das, S. R., Deo, R., de Ferranti, S. D., Floyd, J., Fornage, M., Gillespie, C., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000485 · Cited by 12,591
Heart disease and stroke statistics-2018 update: a report from the american heart association
Benjamin, E. J., Virani, S. S., Callaway, C. W., Chamberlain, A. M., Chang, A. R., Cheng, S., Chiuve, S. E., Cushman, M., Delling, F. N., Deo, R., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000558 · Cited by 7,146
Heart Disease and Stroke Statistics—2016 Update: A Report From the American Heart Association
Mozaffarian, D., Benjamin, E. J., Go, A. S., Arnett, D. K., Blaha, M. J., Cushman, M., Das, S. R., de Ferranti, S., Després, J.-P., Fullerton, H. J., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000350 · Cited by 6,596
Heart Disease and Stroke Statistics—2015 Update: A Report From the American Heart Association
Mozaffarian, D., Benjamin, E. J., Go, A. S., Arnett, D. K., Blaha, M. J., Cushman, M., de Ferranti, S., Després, J.-P., Fullerton, H. J., Howard, V. J., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000152 · Cited by 5,797
Risk Factors for the Development of Psoriasis
Kamiya, K., Kishimoto, M., Sugai, J., Komine, M., & Ohtsuki, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184347 · Cited by 640
Metadata
- Authors
- Love, T. J., Qureshi, A. A., Karlson, E. W., Gelfand, J. M., & Choi, H. K.
- Venue
- Archives of Dermatology
- Publisher
- American Medical Association (AMA)
- Published
- 2011-04-11
- Volume
- 147
- Issue
- 4
- Pages
- 419
- ISSN
- 0003-987X (ISSN-L)
- OpenAlex
- W2092983518
- Cited by
- 274
- References
- 36
- FWCI
- 9.13
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.